Biotechnology News

NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Psyence BioMed Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company focused on the development and supply of nature-derived...

Chairman and Chief Executive Officer, Roger M. Perlmutter, M.D., Ph.D., will participate in a key opinion leader (KOL) event on Thursday, August 20, 2026

Mechelen, Belgium; 18 August 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ:...

Mechelen, België; 18 augustus, 2026, 22.01 CET; gereglementeerde informatie In het kader van het op 9 juni 2026 aangekondigde inkoopprogramma maakt Lakefront Biotherapeutics NV (Euronext &...

FOSTER CITY, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective August 17, 2026, it granted...

Cellution Biologics acquires SimpliDerm®, expanding its human tissue portfolio and entering the U.S. reconstructive surgery market.

ALS pioneer Merit Cudkowicz joins Trethera Advisory Board to support development of TRE-515, an innovative drug for ALS and neurodegenerative diseases.

Applied Biologics announces XWRAP® translational research accepted for presentation at SAWC Fall 2026 in Las Vegas.

Craif closes $33M Series D to launch its non-invasive, urine-based pancreatic cancer test in the U.S. under new Chief Medical Officer Nick Bevins.

Society for Science today announced the selection of 100 educators for it 2026–2027 Advocate Program.